Ottobock Plans Frankfurt IPO, Seeks €709M

Ottobock, the world’s largest prosthetics maker based in Duderstadt, is planning a Frankfurt IPO slated for Oct. 9 that targets a valuation of up to €4.2 billion with shares priced at €62–€66 and an offer period of Sept. 30–Oct. 7. The deal aims to raise roughly €708.7 million by selling about 1.6 million new shares while the controlling Näder family plans to sell about 9.1 million existing shares. Cornerstone investors include Hamburg billionaire Klaus Michael Kühne and a fund managed by U.S. asset manager Capital Group. Proceeds are intended to support the company’s growth and broader market presence. Market participants say the IPO is being watched as a notable European medtech listing that could attract institutional flows.